Preventing colon anastomotic leaks by stenting the superior mesenteric artery
Official title: Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
Run by Medisch Spectrum Twente · NCT07486570 · Data updated 2026-11-12
This trial tests whether placing a stent in the superior mesenteric artery before elective colon surgery can reduce anastomotic leaks in patients over 40 with an asymptomatic >50% SMA stenosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Medisch Spectrum Twente Academic / other |
| Locations | 18 sites (Emmen, Drenthe and 17 other locations) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | February 1, 2028 |
| Study ends | January 1, 2029 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT07486570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults >40 years scheduled for elective colon resection above the recto‑sigmoid junction with a primary anastomosis and an asymptomatic >50% atherosclerotic stenosis at the SMA origin.
✕Probably not a fit
Patients with symptomatic mesenteric ischemia, a >50% celiac artery stenosis, those undergoing extensive multiorgan or T4b/T4c resections, or whose leak risk is driven by non-perfusion factors are unlikely to gain benefit from preventive SMA stenting.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study offers preoperative percutaneous transluminal angioplasty with covered stent placement of the superior mesenteric artery for patients who have an asymptomatic >50% origin stenosis and are scheduled for elective colon resection with a primary anastomosis. Enrolled patients receive the endovascular procedure and mono antiplatelet therapy, then undergo the planned colectomy; outcomes include rate and severity of anastomotic leakage, delayed leaks, mesenteric artery calcification score, surgical complications, readmissions, and quality of life. It is a multicenter effort at hospitals in the Netherlands and enrolls adults over 40 without symptoms of chronic or acute mesenteric ischemia. The trial aims to determine whether preventive SMA revascularization improves perfusion-related surgical outcomes compared with expected baseline rates.
Why it matters
Potential benefit: If successful, preventive SMA stenting could substantially reduce anastomotic leakage after colon surgery, cutting reoperations and improving long-term survival and quality of life.
How similar studies have gone: Retrospective multicenter case-control data linked >50% SMA stenosis to a six-fold higher leak risk and SMA stenting is established for mesenteric ischemia, but preventive stenting in asymptomatic colorectal surgery patients has not been prospectively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>40 years. * Patient scheduled for elective colon resection above the recto-sigmoid junction with a primary anastomosis (side-to-side, side-to-end, or end-to-end). * Presence of an asymptomatic \>50% atherosclerotic origin stenosis of the superior mesenteric artery (SMA) Exclusion Criteria: * All patients with symptomatic chronic or acute mesenteric ischemia (i.e., mesenteric artery stenosis in combination with symptoms as postprandial abdominal pain, fear of eating, altered eating patterns, weight loss, diarrhoea, nausea, or exercise-induced abdominal pain). * Presence of a \>50% stenosis of the celiac artery, regardless of the underlying pathology (i.e., intra-articular atherosclerosis, intra articular thrombus or external compression by the median accurate ligament). * Simultaneous performed during the colon resection: a substantial abdominal organ resection, or T4b/T4c colon tumour resection, or a second colon anastomosis or a diverting stoma * History of mesenteric revascularization, including endovascular stenting, thrombectomy, or bypass surgery involving any of the mesenteric arteries * Patients with a history of heparin induced thrombocytopenia-type 2 due to contraindication for VBX Stent Graft. * Patients with a contra-indication for mono antiplatelet therapy with Ascal due to comorbidities, allergy or intolerance. * Pregnancy
Where it's running
-
Gelre ziekenhuis
Apeldoorn, Gelderland, Netherlands Recruiting -
Zuyderland
Heerlen, Limburg, Netherlands Recruiting -
Maastricht Universitair Medisch Centrum (MUMC+)
Maastricht, Limburg, Netherlands Recruiting -
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, North Brabant, Netherlands Recruiting -
Noordwest Ziekenhuisgroep
Alkmaar, North Holland, Netherlands Recruiting -
Ziekenhuisgroep Twente
Almelo, Overijsel, Netherlands Recruiting
Show 12 more locations
-
Medisch Spectrum Twente
Enschede, Overijsel, Netherlands Recruiting -
Nij Smellinghe
Drachten, Provincie Friesland, Netherlands Recruiting -
Franciscus
Rotterdam, South Holland, Netherlands Recruiting -
Maasstad ziekenhuis
Rotterdam, South Holland, Netherlands Recruiting -
Treant
Emmen, Drenthe, Netherlands Not yet recruiting -
Meander
Amersfoort, Gelderland, Netherlands Not yet recruiting -
Spaarne Gasthuis
Haarlem, North Holland, Netherlands Not yet recruiting -
Martini Ziekenhuis
Groningen, Provincie Groningen, Netherlands Not yet recruiting -
Universitair Medisch Centrum Groningen
Groningen, Provincie Groningen, Netherlands Not yet recruiting -
Haaglanden Medisch Centrum
The Hague, South Holland, Netherlands Not yet recruiting -
Diakonessenhuis
Utrecht, Utrecht, Netherlands Not yet recruiting -
Albert Schweitzer ziekenhuis
Dordrecht, Zuid, Netherlands Not yet recruiting
Study contacts
- Principal investigator: Bob H. Geelkerken, Prof. dr. — Medisch Spectrum Twente
- Study coordinator: Koen J. Vree Egberts, MD, PhD Candicate
- Email: koen.vreeegberts@mst.nl
- Phone: +31 6 15247413
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bowel Sounds and Day-to-Day Recovery After Colorectal Cancer Surgery
This study will test whether monitoring bowel sounds before and after colorectal cancer surgery can predict how quickly patients recover bowel function and resume eating.
-
Bilateral ESPB versus OSTAPB for postoperative pain after colorectal surgery
This study tests whether, after open colorectal surgery, an ultrasound-guided bilateral erector spinae plane block works better or the bilateral OSTAP block works better for controlling pain.
-
Using fingertip CRP point-of-care tests to spot leaks after elective colorectal surgery
This project will see if daily fingertip CRP point-of-care tests can detect anastomotic leaks early in people having elective colorectal surgery.
-
Blood biomarker testing for mesenteric ischemia
This study will test whether specific blood biomarkers can reliably detect mesenteric ischemia and distinguish non‑transmural from transmural disease in adults with suspected mesenteric artery problems.
-
STIME: Preventing serious mental health problems in children and teens
This project will test five STIME prevention programs to see if they help children and adolescents aged 3–17 with early signs of mental health difficulties stay well compared with usual care.
-
Peripheral autonomic plus TAP blocks for pain after minimally invasive left-sided colorectal surgery
This will try adding a peripheral autonomic block (targeting the superior hypogastric and inferior mesenteric plexuses) plus a TAP block to standard pain control in adults having elective minimally invasive left-sided colorectal surgery to see if it reduces pain and opioid use in the first 48 hours.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.